ID
25811
Description
Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease
Keywords
Versions (2)
- 9/20/17 9/20/17 -
- 9/20/17 9/20/17 -
Uploaded on
September 20, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
visit baseline eligibility Ropinirole CR Ropinirole IR Monotherapy 101468/168
visit baseline eligibility Ropinirole CR Ropinirole IR Monotherapy 101468/168
Description
ELIGIBILITY QUESTION
Alias
- UMLS CUI-1
- C1516637
Description
EXCLUSION CRITERIA
Alias
- UMLS CUI-1
- C0680251